U.S. Severely Restricts Johnson & Johnson COVID Vaccine Over Blood Clots

U.S. Severely Restricts Johnson & Johnson COVID Vaccine Over Blood Clots


U.S. regulators are severely restricting the Johnson & Johnson COVID-19 vaccine for causing blood clots in recipients.

The Food and Drug Administration (FDA) is giving a recommendation that the Johnson & Johnson jab only be administered if specifically requested or there are no other vaccines available.

Trending: BREAKING: Senate Passes $40 Billion Package to Ukraine, Blocks $48 Billion Aid for Restaurants and Other Small Businesses

“If there’s an alternative that appears to be equally effective in preventing severe outcomes from COVID-19, we’d rather see people opting for that,” said FDA vaccine chief Dr. Peter Marks. “But we’ve been careful to say that — compared to no vaccine — this is still a better option.”

From now on, all Johnson & Johnson COVID-19

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend